Biotech MapLight Jumps 23% in First US IPO Using Shutdown Fix
MapLight Therapeutics Inc. shares jumped as much as 23% after the biotechnology firm raised $258.9 million in an initial public offering and private placement.
By Avalon Pernell ยท Bloomberg
MapLight Therapeutics Inc. shares jumped as much as 23% after the biotechnology firm raised $258.9 million in an initial public offering and private placement.